HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-/SMAD signalling pathway

作者:Lucarini Laura; Durante Mariaconcetta; Lanzi Cecilia; Pini Alessandro; Boccalini Giulia; Calosi Laura; Moroni Flavio; Masini Emanuela; Mannaioni Guido
来源:JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21(2): 324-335.
DOI:10.1111/jcmm.12967